XBKK
CMR
Market cap173mUSD
Nov 12, Last price
1.43THB
Name
Chiang Mai Ram Medical Business PCL
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Chiang Mai Ram Medical Business Public Company Limited is a Thai healthcare provider primarily operating medical facilities. The company delivers a comprehensive array of medical services, encompassing core specializations such as internal medicine, cardiology, general practice, pediatrics, orthopedics, various surgical fields (general and pediatric), obstetrics-gynecology, radiology, dentistry, anesthesiology, otolaryngology (ENT), and ophthalmology. Beyond these fundamental areas, CMR.BK manages specialized clinics for conditions like urological, neurological, endocrine, oncological, hematological, plastic surgery, gastrointestinal, and dermatological issues, alongside dedicated clinics for infertility and gynecologic oncology. The company further extends its offerings to include a variety of diagnostic and therapeutic services such as dental care, advanced imaging (X-ray, CT colonoscopy), cardiac catheterization, gynecologic cancer treatments, back pain management, physical therapy and rehabilitation, surgical operating theatres, laboratory examinations (including real-time PCR), ambulance services, CRD, and comprehensive health check-ups. Additionally, it provides insurance products. CMR.BK operates its primary medical care center under the name Lanna Hospital. Established in 1974, the company's headquarters are located in Chiang Mai, Thailand. It functions as a subsidiary of Vibhavadi Medical Center Public Company Limited.
Key people
Racha Somboonranasin
Chairman of the Board · since 2008
Dusit Srisakul
Managing Director of Hospital, Executive Director, Director · since 2004
Chamnan Chanapai
Director · since 2008
Sumeth Handagoon
Executive Director, Director · since 2007
Ruechid Kanjanapitak
Director · since 2017
Teerayuth Niyomgool
Deputy Managing Director of Hospital, Executive Director, Director · since 2004
Director
Varaphan Unachak
Director
Krirk Jittalan
Deputy Managing Director, Independent Director · since 2009
Suthisak Kanaprach
Independent Director · since 2008
Papat Supaokit
Independent Director · since 2008
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||